Be the first to know about all things Omnipod® 5
More than the next generation of Pod Therapy — Omnipod® 5 is a revolution in simplifying diabetes care.
We are delighted to hear that the Omnipod® 5 Automated Insulin Delivery System has been approved by the TGA.
This is the first step towards commercialising the Omnipod® 5 system in Australia. There are several steps involved around commercial readiness, including finalising the cloud infrastructure and securing the access pathway for Australian customers. Insulet is excited to bring this technology to the Australian type 1 diabetes community and will provide updates as we approach launch.
Insulet will support a transition pathway to Omnipod® 5 for new and existing customers with more information to follow.
To stay up to date on Omnipod® 5 information your patients can register for updates at the link https://www.omnipod.com/en-au/omnipod-5-interest-list
To stay up to date with Omnipod® 5 news and updates, please register your interest by signing up below on our healthcare professional specific form.
Join the Omnipod® 5 Interest List
Fill out the form below to keep up to date on Omnipod® innovation and know when Omnipod® 5 becomes available for patients in Australia.
Please submit your details to receive news and marketing emails about the Omnipod® 5 Automated Insulin Delivery System and other Insulet products and services. You can unsubscribe from these emails at any time by clicking “unsubscribe” in any email you receive. Please see our Privacy Policy for our contact details and more information on how we process your personal information.